Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20829940 | 0.89 | CA2 (0.48) | CA2CA9ALDH1A1MEN1KMT2A | |
| SCHEMBL28099596 | 0.87 | CA2 (0.47) | CA2CA9ALDH1A1MAOBMEN1 | |
| SCHEMBL15057676 | 0.85 | PAOX (0.47) | CA2CA9ALDH1A1MAOBMEN1 | |
| SCHEMBL13887521 | 0.82 | CA2 (0.48) | CA2CA9ALDH1A1MEN1KMT2A | |
| SCHEMBL21981211 | 0.82 | CA2 (0.48) | CA2CA9ALDH1A1MEN1BLM | |
| SCHEMBL22688014 | 0.80 | CA2 (0.45) | CA2CA9 | |
| SCHEMBL23568300 | 0.80 | CA2 (0.42) | CA2CA9CYP2C19TSHR | |
| SCHEMBL16014560 | 0.80 | CA2 (0.47) | CA2CA9ALDH1A1MEN1KMT2A | |
| SCHEMBL28480824 | 0.78 | CA2 (0.46) | CA2CA9ALDH1A1MEN1KMT2A | |
| SCHEMBL18063509 | 0.78 | SLC6A5 (0.38) | CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111920959-B | ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof | 中国药科大学 | 2022-03-25 | — | — | CN | claimed |
| CN-111920959-A | ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof | 中国药科大学 | 2020-11-13 | — | — | CN | claimed |
| US-12629458-B2 | Agent to be used in intraocular membrane detachment surgery | FUKUOKA UNIVERSITY (JP) | 2026-05-19 | — | — | US | disclosed |
| CN-118403227-A | Formulations for use in intraocular lens stripping | 学校法人福冈大学 | 2024-07-30 | — | — | CN | disclosed |
| CN-115209926-B | Formulations for use in intraocular lens stripping | 学校法人福冈大学 | 2024-05-14 | — | — | CN | disclosed |
| US-20230136938-A1 | AGENT TO BE USED IN INTRAOCULAR MEMBRANE DETACHMENT SURGERY | FUKUOKA UNIVERSITY (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4129353-A1 | AGENT TO BE USED IN INTRAOCULAR MEMBRANE DETACHMENT SURGERY | Fukuoka University (JP) | 2023-02-08 | — | — | EP | disclosed |
| CN-111920959-B | ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof | 中国药科大学 | 2022-03-25 | — | — | CN | disclosed |
| CN-111920959-A | ROS (reactive oxygen species) -responsive heparin polysaccharide nano prodrug compound based on click reaction, nano preparation, and preparation method and application thereof | 中国药科大学 | 2020-11-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629458-B2 | Agent to be used in intraocular membrane detachment surgery | VIM, VEGFA, MKI67 | CA2 982/4885CA9 192/4885ALDH1A1 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.